Announcements Trials

Browse Landscape

Phase

Phase 1 39 Phase 1/2 21 Phase 2 17 Phase NA 9 Phase 3 6 Phase EARLY_PHASE1 5 Phase 4 2 Phase 2/3 1

Status

Completed 101 Recruiting 76 Terminated 60 Active not recruiting 35 Unknown 30 Not yet recruiting 24 Withdrawn 14 Enrolling by invitation 3 Suspended 1

Sponsor Class

OTHER 5 NIH 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Neoplasms 1 Carcinoma, Hepatocellular 1

Interventions

lenvatinib 1 Sorafenib 1 Folfox protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Suspended × INDUSTRY × Clear all

NCT05033522 2025-10-23

ALIVE

Mirror Biologics, Inc.

Phase 2/3 Suspended

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡